Parent Group Education for Adolescent Type 1 Diabetes Transition
(GETIT-Parent Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether group education for parents can help adolescents with type 1 diabetes (T1D) transition more smoothly into adulthood. Researchers aim to determine if these sessions, combined with regular diabetes care, ease teens' management of their condition. Parents will join group discussions led by a diabetes social worker to share experiences and strategies. The trial targets parents whose teens (ages 14-16) have had T1D for at least six months and receive care at a specific Montreal hospital. As an unphased trial, this study offers families a unique opportunity to contribute to research that could enhance diabetes management for teens.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether participants need to stop taking their current medications.
What prior data suggests that group education sessions for parents are safe?
Research has shown that group education sessions for parents of teens with type 1 diabetes are generally safe. Past studies reported no major negative effects from these educational programs. These sessions help parents and their teens manage diabetes as they transition from child to adult care. The focus is on improving self-care and reducing stress, both crucial during this time. While this trial aims to enhance the program, existing evidence suggests that the sessions are well-received and helpful for both parents and teens.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it offers a new way to support parents of adolescents with Type 1 Diabetes during the transition to adulthood. Unlike the typical approach that focuses solely on individual medical care, this method adds group education sessions for parents. These sessions, led by a diabetes social worker, encourage parent-driven discussions on adolescent and transition care topics, making it a more personalized and supportive experience. This approach aims to empower parents with shared insights and strategies, potentially leading to better management of their child's condition during this critical phase.
What evidence suggests that group education sessions for parents could be effective for improving the transition for adolescents with type 1 diabetes?
Research has shown that group education sessions benefit teenagers with type 1 diabetes (T1D) and their families. In this trial, one group of participants will receive group education sessions for parents alongside usual diabetes care. These sessions improve skills needed to manage diabetes and prepare for the transition from child to adult healthcare. For instance, studies have found that such programs can lead to better blood sugar control, as evidenced by improved hemoglobin A1c (HbA1c) levels. Additionally, these programs often boost confidence in managing diabetes, which is crucial for long-term health. Overall, group education for parents aims to support better health outcomes for teenagers with T1D.13678
Who Is on the Research Team?
Meranda Nakhla, MD
Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Are You a Good Fit for This Trial?
This trial is for parents fluent in English or French, of adolescents aged 14-16 with type 1 diabetes (T1D), who are patients at Montreal Children's Hospital. It excludes those already in the GET-IT-T1D adolescent trial or with severe neurocognitive disabilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Parent group education sessions plus usual diabetes care every 3 months for 12 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Group education sessions for parents
- Usual diabetes care
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
Diabetes Canada
Collaborator